UBS downgraded Revvity to Neutral from Buy with a price target of $125, up from $105. The company’s growth algorithm is now more similar to peers versus upside differentiated, the analyst tells investors in a research note. The firm says that following another long-range plan reduction last week and mixed channel feedback, it increasingly questions Revvity’s ability to drive differential growth. The company’s Revvity’s second half of 2023 results and 2024 framing thoughts suggest its growth prospects are more in line with peers than upside differentiated, contends UBS.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RVTY:
- Early notable gainers among liquid option names on January 9th
- Revvity upgraded to Outperform from In Line at Evercore ISI
- Early notable gainers among liquid option names on December 22nd
- Revvity initiated with an Equal Weight at Wells Fargo
- Revvity initiated with neutral view at Wolfe Research, here’s why